Skip to main content
Erschienen in: World Journal of Urology 12/2020

04.03.2020 | Original Article

Preliminary study on the application of en bloc resection combined with near-infrared molecular imaging technique in the diagnosis and treatment of bladder cancer

verfasst von: Yongjun Yang, Xiaofeng Yang, Chao Liu, Jiawei Li

Erschienen in: World Journal of Urology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

To evaluate the surgical safety of en bloc resection of bladder tumor (ERBT) and the effectiveness of ERBT combined with near-infrared (NIR) imaging technique in the diagnosis and treatment of non-muscle invasive bladder cancer (NMIBC).

Methods

From October 2017 to June 2018, 26 patients newly diagnosed with single NMIBC were included in this retrospectively trial. All patients received ERBT with monopolar current. After surgery, the fresh specimen was incubated with anti-CD47-Alexa Fluor 790, and then imaged under NIR imaging technique. Operative details, intraoperative and postoperative complications of ERBT regarded as safety outcomes, the mean fluorescence intensity (MFI) of tumor tissue and adjacent normal background tissue, and 12 months follow-up data were analyzed.

Results

Of 26 collected patients, obturator nerve reflex was occurred in six patients during tumor resection, and only one patient was observed with bladder perforation. In NIR gray image, the gray scale of MFI of tumor tissue were 132.31 ± 6.67 and the adjacent normal background tissue were 52.27 ± 12.09. The result showed a significantly higher MFI signals in tumor tissue compared to adjacent normal background tissue (P < 0.001). The recurrence-free survival rate at 12 month was 96.15%.

Conclusions

ERBT with monopolar current is a safe and feasible technique to treat patients with NMIBC. A integrated bladder tumor tissue-bound anti-CD47-Alexa Fluor 790 was detected under NIR light, and the NIR image indicates that higher MFI signals in surgical margin is a predictive factor for residual tumor in patients with NMIBC after ERBT.
Literatur
2.
Zurück zum Zitat Chen WQ, Zheng RS, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132CrossRef Chen WQ, Zheng RS, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132CrossRef
3.
Zurück zum Zitat Cumberbatch MGK, Jubber I, Black PC et al (2018) Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol 74:784–795CrossRef Cumberbatch MGK, Jubber I, Black PC et al (2018) Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol 74:784–795CrossRef
4.
Zurück zum Zitat Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466–475 (discussion 475–477)CrossRef Sylvester RJ, van der Meijden AP, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466–475 (discussion 475–477)CrossRef
5.
Zurück zum Zitat Svatek RS, Hollenbeck BK, Holmäng S et al (2014) The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 66:253–262CrossRef Svatek RS, Hollenbeck BK, Holmäng S et al (2014) The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 66:253–262CrossRef
6.
Zurück zum Zitat Avallone MA, Sack BS, El-Arabi A et al (2017) Ten-year review of perioperative complications after transurethral resection of bladder tumors: analysis of monopolar and plasma-kinetic bipolar cases. J Endourol 31:767–773CrossRef Avallone MA, Sack BS, El-Arabi A et al (2017) Ten-year review of perioperative complications after transurethral resection of bladder tumors: analysis of monopolar and plasma-kinetic bipolar cases. J Endourol 31:767–773CrossRef
8.
Zurück zum Zitat Kramer MW, Bach T, Wolters M et al (2011) Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer. World J Urol 29:433–442CrossRef Kramer MW, Bach T, Wolters M et al (2011) Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer. World J Urol 29:433–442CrossRef
9.
Zurück zum Zitat Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 33(12):1937–1943CrossRef Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 33(12):1937–1943CrossRef
10.
Zurück zum Zitat Kramer MW, Altieri V, Hurle R et al (2017) Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer. Eur Urol Focus 3:567–576CrossRef Kramer MW, Altieri V, Hurle R et al (2017) Current evidence of transurethral en-bloc resection of nonmuscle invasive bladder cancer. Eur Urol Focus 3:567–576CrossRef
11.
Zurück zum Zitat Babjuk M, Böhle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461CrossRef Babjuk M, Böhle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447–461CrossRef
12.
Zurück zum Zitat Bernhard K, van den Berg Nynke S, Robert E et al (2019) CD47-targeted near-infrared photoimmunotherapy for human bladder cancer. Clin Cancer Res 25:3561–3571CrossRef Bernhard K, van den Berg Nynke S, Robert E et al (2019) CD47-targeted near-infrared photoimmunotherapy for human bladder cancer. Clin Cancer Res 25:3561–3571CrossRef
13.
Zurück zum Zitat Panchuk-Voloshina N, Haugland RP, Bishop-Stewart J et al (1999) Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem 47:1179–1188CrossRef Panchuk-Voloshina N, Haugland RP, Bishop-Stewart J et al (1999) Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J Histochem Cytochem 47:1179–1188CrossRef
14.
Zurück zum Zitat Naselli A, Introini C, Germinale F et al (2012) En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int 109:960–963CrossRef Naselli A, Introini C, Germinale F et al (2012) En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int 109:960–963CrossRef
15.
Zurück zum Zitat Pan Y, Volkmer JP, Mach KE et al (2014) Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. Sci Transl Med 6:260ra148CrossRef Pan Y, Volkmer JP, Mach KE et al (2014) Endoscopic molecular imaging of human bladder cancer using a CD47 antibody. Sci Transl Med 6:260ra148CrossRef
16.
Zurück zum Zitat De NC, Franco G, Cindolo L et al (2014) Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol 40(1):90–95CrossRef De NC, Franco G, Cindolo L et al (2014) Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol 40(1):90–95CrossRef
17.
Zurück zum Zitat Perlis N, Zlotta AR, Beyene J et al (2013) Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. Eur Urol 64:421–430CrossRef Perlis N, Zlotta AR, Beyene J et al (2013) Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review. Eur Urol 64:421–430CrossRef
18.
Zurück zum Zitat Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 33:1937–1943CrossRef Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol 33:1937–1943CrossRef
20.
Zurück zum Zitat Comploj E, Dechet CB, Mian M et al (2014) Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer. World J Urol 32:1219–1223CrossRef Comploj E, Dechet CB, Mian M et al (2014) Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer. World J Urol 32:1219–1223CrossRef
21.
Zurück zum Zitat Mori K, D'Andrea D, Enikeev DV et al (2020) En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. Curr Opin Urol 30:41–47CrossRef Mori K, D'Andrea D, Enikeev DV et al (2020) En bloc resection for nonmuscle invasive bladder cancer: review of the recent literature. Curr Opin Urol 30:41–47CrossRef
22.
Zurück zum Zitat Cumberbatch MGK, Foerster B, Catto JWF et al (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 73(6):925–933CrossRef Cumberbatch MGK, Foerster B, Catto JWF et al (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 73(6):925–933CrossRef
23.
Zurück zum Zitat Guzzo TJ, Magheli A, Bivalacqua TJ et al (2009) Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette–Guerin-refractory bladder cancer. Urology 74:1276–1280CrossRef Guzzo TJ, Magheli A, Bivalacqua TJ et al (2009) Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette–Guerin-refractory bladder cancer. Urology 74:1276–1280CrossRef
24.
Zurück zum Zitat Gontero P, Sylvester R, Pisano F et al (2015) Prognostic factors and risk groups in T1G3 non-muscle -invasive bladder cancer patients initially treated with Bacillus Calmette–Guérin: results of a retrospective multicenter study of 2451 patients. Eur Urol 67:74–82CrossRef Gontero P, Sylvester R, Pisano F et al (2015) Prognostic factors and risk groups in T1G3 non-muscle -invasive bladder cancer patients initially treated with Bacillus Calmette–Guérin: results of a retrospective multicenter study of 2451 patients. Eur Urol 67:74–82CrossRef
25.
Zurück zum Zitat Zhang D, Yao L, Yu S et al (2020) Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary non muscle-invasive bladder cancer: a meta-analysis. World J Surg Oncol 18:4CrossRef Zhang D, Yao L, Yu S et al (2020) Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary non muscle-invasive bladder cancer: a meta-analysis. World J Surg Oncol 18:4CrossRef
26.
27.
Zurück zum Zitat Onishi T, Sugino Y, Shibahara T et al (2017) Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. BJU Int 119:276–282CrossRef Onishi T, Sugino Y, Shibahara T et al (2017) Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer. BJU Int 119:276–282CrossRef
Metadaten
Titel
Preliminary study on the application of en bloc resection combined with near-infrared molecular imaging technique in the diagnosis and treatment of bladder cancer
verfasst von
Yongjun Yang
Xiaofeng Yang
Chao Liu
Jiawei Li
Publikationsdatum
04.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-020-03143-w

Weitere Artikel der Ausgabe 12/2020

World Journal of Urology 12/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.